A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

NCT04722523 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head Cancer
Head Cancer Neck
Neck Cancer
Head and Neck Squamous Cell Carcinoma
HNSCC

Interventions

DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Docetaxel
DRUG: Cetuximab
DRUG: Cemiplimab
PROCEDURE: Surgical Resection of Primary +/- Neck Dissection
RADIATION: Post-operative radiation therapy
DRUG: Paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]